Cellivery Therapeutics, Inc.

    Cellivery Therapeutics, Inc.

    KKRX:268600
    6,680.00
    KRW
    -2,850.00
    (-29.91%)
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    251.26
    218.94
    66.72
    23.63
    115.06
    919.75
    514.85
    648.68
    Basic EPS, GAAP
    -1,359.5
    -325
    -632.25
    -535.26
    -834
    -2,985
    -889
    -162
    Free Cash Flow per Basic Share
    -78.61
    -160.82
    -395.93
    -538.04
    -812.88
    -2,959.87
    -241.69
    39.19
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -3,732.85
    -2,258.46
    -2,134.93
    -2,588.67
    -3,172.73
    -6,847.8
    -5,591.04
    - -
    Tangible Book Value per Share
    -2,539.21
    1,736.51
    868.48
    1,170.99
    2,130.94
    375.45
    -728.8
    -592.18
    Basic Weighted Avg Shares
    11
    21
    31
    32
    34
    25
    37
    38
    Sales/Revenue/Turnover
    2,774
    4,512
    2,074
    762
    3,872
    23,158
    18,863
    24,536
    Operating Margin (%)
    -125.54
    -90.92
    -703.31
    -2,312.53
    -724.36
    -288.85
    -103.71
    -57.64
    Depreciation Expense
    440
    507
    998
    1,039
    1,461
    5,195
    4,950
    2,032
    Net Income, GAAP
    -15,008
    -6,698
    -19,650
    -17,248
    -28,069
    -75,159
    -32,571
    -6,127
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -541.08
    -148.45
    -947.58
    -2,264.83
    -724.84
    -324.54
    -172.67
    -24.97
    Working Capital
    -22,406
    34,248
    26,281
    53,397
    72,239
    -25,565
    -46,778
    -40,027
    LT Debt
    - -
    - -
    - -
    20,721
    23,639
    18,539
    748
    - -
    Total Equity
    -28,005
    35,826
    27,283
    38,393
    75,007
    10,454
    -26,168
    -22,399
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    KRW

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    44,783
    36,356
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    369
    328
    - -
    Preferred Equity and Hybrid Capital
    62
    16
    - -
    Shares Outstanding
    37
    37
    37
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    KRW

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    5,732
    3,416
    2,911
    Cash, Cash Equivalents & STI
    590
    65
    - -
    Accounts Receivable, Net
    1,393
    1,101
    - -
    Inventories
    1,447
    1,617
    - -
    Total Current Liabilities
    53,894
    44,116
    42,938
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    44,783
    36,356
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    KRW

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -64.82%
    -350.3%
    Free Cash Flow
    - -
    90.85%
    -88.12%
    Net Income, GAAP
    - -
    70.99%
    -56.66%
    Sales/Revenue/Turnover
    - -
    154.13%
    -18.55%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    8,093
    264
    129
    5,591
    23,158
    2023
    7,504
    4,800
    54
    17,997
    18,863
    2024
    3,135
    1,499
    1,905
    - -
    - -

    Quarterly Earnings Per Share

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -474.35
    -236.5
    -425
    - -
    -2,985
    2023
    -410.66
    -335
    -106.66
    - -
    -889
    2024
    -74
    -36
    - -
    - -
    - -

    Quarterly Dividends Per Share

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business